Source link : https://www.newshealth.biz/health-news/fda-warns-about-anaphylaxis-risk-with-ms-drug/
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer acetate (Copaxone, Glatopa), the agency announced on Wednesday. The warning indicates that anaphylaxis can occur at any time, from as early as after the first dose or after doses administered years after starting treatment. “We are […]
Author : News Health
Publish date : 2025-01-22 20:09:48
Copyright for syndicated content belongs to the linked Source.
inHealth